We performed a similar benchmarking on well-established PAM50-based (Parker et al., 2009) breast cancer (BRCA) subtypes: luminal A (LUMA), luminal B (LUMB), HER2-enriched (HER2), basal-like (BASAL), and normal-like (NORMAL; Figure 4b). Here, ERBB2 is linked to breast cancer.